Epidemiology of Myocardial Infarction by Jayaraj, Joshua Chadwick et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 2
Epidemiology of Myocardial Infarction
Joshua Chadwick Jayaraj, Karapet Davatyan,
S.S. Subramanian and Jemmi Priya
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/intechopen.74768
Abstract
Coronary heart disease (CHD) is the leading cause of morbidity and mortality throughout
the world. The most common form of CHD is the myocardial infarction. It is responsible
for over 15% of mortality each year, among the vast majority of people suffering from non-
ST-segment elevation myocardial infarction (NSTEMI) than ST-segment elevation myo-
cardial infarction (STEMI). The prevalence of myocardial infarction (MI) is higher in men
in all age-specific groups than women. Although the incidence of MI is decreased in the
industrialized nations partly because of improved health systems and implementation
of effective public health strategies, nevertheless the rates are surging in the developing
countries such as South Asia, parts of Latin America, and Eastern Europe. The modifiable
risk factors represent over 90% of the risk for acute MI. The risk factors such as dyslipid-
emia, smoking, psychosocial stressors, diabetes mellitus, hypertension, obesity, alcohol
consumption, physical inactivity, and a diet low in fruits and vegetables were strongly
associated with acute MI.
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1. Introduction
The widely accepted definition of epidemiology is “the study of the distribution and determi-
nants of health-related states or events in specified populations, and the application of this
study to the control of health problems” [1]. The overarching aim of epidemiology is to
improve the control of disease through both prevention and treatment that will decrease
morbidity and mortality due to the disease and will increase the quality of life of those who
have a severe illness like coronary artery diseases, e.g., myocardial infarction.
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
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1.1. Coronary heart disease
The most common cause of coronary heart disease (CHD) is atherosclerosis of coronary
arteries [2]. Atherosclerosis causes an inadequate supply of oxygen for a given a myocardial
demand leading to myocardial hypoxia.
1.2. Atherosclerosis
The sequence of endothelial dysfunction, plaque formation consisting of lipids and smooth
muscles, and associated inflammation causes atherosclerotic plaque [3]. Over these plaques
rupture and thrombosis causing further narrowing of arteries and occlusion of blood flow can
occur.
Although beyond the scope of this chapter, atherosclerosis implies disturbances in the coro-
nary circulation as well as the microcirculation dysfunction.
1.3. Burden of coronary heart disease
Globally, cardiovascular diseases (CVDs) are the number one cause of mortality. According to
the World Health Organization (WHO), it is estimated that 7.4 million deaths were due to
coronary heart disease in 2015. Eighty-two percent of deaths in low- and middle-income
countries are accountable for CVD. Figure 1 shows the age-standardized estimate of mortality
by cardiovascular diseases and diabetes per 100,000 people. It is estimated that 23.6 million
people will die from CVDs by 2030. These are projected to remain the leading cause of
mortality.
1.4. Geographic variations in coronary heart disease
Worldwide the prevalence of CHD is increasing albeit there are regional variations due to the
influence of economies, industrialization, and advancement in healthcare systems [5]. Data
from the USA suggest about 25% of deaths in the USA are associated with heart disease each
year [6]. An American dies due to myocardial infarction (MI) every 60 seconds [6]. The
incidence of CHD in the western world is decreasing even though the risk factors for CHD
such as hypertension, diabetes mellitus, and obesity are increasing. The decline is due to
strengthening healthcare systems due to relative advancement in therapeutic and invasive
interventions. As a result, CHD costs the USA about $200 billion each year [7]. The total cost
includes not only the cost of healthcare services or medications, but it also includes the loss of
productivity [7].
As Asia comprises over one-third of the world population, its experience on the prevalence
of CHD is significant. In India, CHD may not be explained due to the traditional risk factors
[8], whereas in China, CHD remains the second most cause of the deaths. Chinese cardiovas-
cular medicine focusses centrally on prevention by shifting its focus from symptom-based
therapy to lifestyle-guided improvement [9]. Trends in mortality from CHD were favorable
in European Union countries, whereas in Eastern European countries, mortality from CHD
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remains exceptionally high [10]. CVD death rates have been significantly decreasing in most of
the countries of Latin America despite the disparities in current trends [11].
The WHO has identified very cost-effective interventions that are feasible to be implemented
even in low resource settings for averting the global epidemic of CVDs.
2. Myocardial infarction
2.1. Defining myocardial infarction
The most common form of CHD is the myocardial infarction (MI) [12]. MI occurs when a
coronary artery is occluded or almost occluded, which creates a severe reduction in the blood
flow, causing some of the heart muscle being supplied by that artery to become infarcted [13].
Figure 1. Cardiovascular diseases and diabetes, deaths per 100,000 people. Source: Global Health Observatory data
repository and World Health Organization [4].
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There are two clinical settings of MI—ST-segment elevation myocardial infarction (STEMI) and
non-ST-segment elevation myocardial infarction (NSTEMI). STEMI is recognized by character-
istic changes on the electrocardiography (ECG) [14]. One of those ECG changes is the typical
elevation in the “ST segment” which is called as STEMI. On the contrary the absence of ST-
segment elevation and the presence of positive cardiac biomarker such as troponin are called
NSTEMI [15].
In the following sections, prevalence and incidence of myocardial infarction are elaborated.
Prevalence is defined as the number of diseased individuals present in the population at a
specific time. The incidence rate is determined as the number of new cases of a disease that
occur during a specific time. The estimates are reported from various data sources such as
general practice registries and self-reported by the patient through the national survey. The
reliability of the data is based on the data source.
2.2. Prevalence of myocardial infarction
According to 2014, based on the self-reported national survey of the UK, the prevalence of MI
was reported as 640,000 in men and 275,000 in women; this represents about 915,000 people
that have suffered an MI in the UK. In 2013, the prevalence of MI in men was about three times
higher than for women in the UK [16]. As shown in Figure 2, the prevalence of age-specific MI
extends from 0.06% of men <45 years of age to 2.46% of those ≥75 years old.
In contrast to these developed countries, South Asian countries (India, Pakistan, Sri Lanka,
Bangladesh, and Nepal) have the highest prevalence of MI seen in younger than 45 years of
age compared to those older than 60 years.
2.3. Incidence of myocardial infarction
Prevalence reflects first (acute) MI and MI in patients who had a previous MI. The incidence of
MI only reflects the former. The incidence of MI has been declining in developed countries,
including the USA and the UK.
The recent estimates of the incidence of MI in the USA are about 525,000 based on AHA data
[18]. The Mozaffarian Study reported data comparing and contrasting the incidence of myo-
cardial infarction in white men and women versus and black men and women. The study
concludes that the incidence of myocardial infarction was more significant among black men
(12.9/100,000 males) who are in the age group 75–84 years of age than whites for both men (9.1/
100,000 males) and women (7.8/100,000 females). Similar trends exist in other age groups and
their counterparts (Figure 3) [19]. It is essential to assess the effectiveness of public health
strategies to fight MI.
Regarding the clinical type of MI, it has been estimated that incidence rates (per 100,000) of
STEMI decreased appreciably (121 to 77), whereas those incidence rates of NSTEMI declined
slightly (126 to 132) [20]. In a landmark study, no variation was seen in all-cause mortality for
both STEMI and NSTEMI between 6 months and 4 years of follow-up. But, STEMI patients
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have a worse long-term prognosis matched to NSTEMI patients [21]. Other studies have
shown a worse 7-year mortality rate for NSTEMI patients than STEMI patients [22].
2.4. Risk factors
The INTERHEART study evaluated the prevalence of nine potentially modifiable risk factors
in more than 15,000 cases with the first acute MI and matched with about 15,000 asymptomatic
age- and sex-matched controls [23]. Nine risk factors were strongly associated with acute MI in
the 52 countries included in the trial. The modifiable risk factors represent over 90% of the risk
for acute MI. Diabetes mellitus is a significant predictor of adverse cardiac outcomes, espe-
cially in women. It is considered to be a coronary heart disease equivalent (Tables 1–4) [24, 25].
2.5. Summary
It is evident that MI is the leading cause of morbidity and mortality worldwide. It is responsi-
ble for over 15% of mortality each year, among the vast majority of people suffering from
NSTEMI than STEMI. The prevalence of MI is higher among men in all age-specific groups
than women. Although the incidence of MI is decreased in the industrialized nations partly
Figure 2. Age-specific prevalence of MI in the UK, 2014 [17]. Adapted from Clinical Practice Research Datalink (CPRD),
2014. Evaluations are based on records from a sample of general practices in each of the constituent nations of the UK.
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because of improved health systems and implementation of effective public health strategies,
nevertheless the rates are surging in the developing countries such as South Asia, parts of Latin
America, and Eastern Europe. The modifiable risk factors account for more than 90% of the
risk for acute MI. Nine risk factors such as dyslipidemia, smoking, psychosocial stressors,
Figure 3. Incidence of myocardial infarction by age, sex, and race in the USA, 2015 [19]. Adapted from Heart Disease and
Stroke Statistics—2015 update: A report from the American Heart Association.
CHD risk equivalents • Noncoronary atherosclerotic disease (e.g., carotid, peripheral, abdominal aortic
aneurysm)
• Diabetes mellitus
• Chronic kidney disease
CHD-established risk
factors
• Dyslipidemia, smoking, psychosocial stressors, diabetes mellitus, hypertension, obesity,
alcohol consumption, physical inactivity, and diet low in fruits and vegetables
• Age (especially >50 in men and postmenopausal women)
• Family history of CHD in first-degree relative age < 50 (men) and age < 60 (women)
Table 1. Risk factors for coronary heart disease (CHD).
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Test Onset of abnormality Duration of abnormality
ECG Immediately at onset of chest pain ST elevation progresses to Q-waves over several days to weeks
Myoglobin 1–4 hours 1–2 days
CK-MB 4–6 hours 1–2 days
Troponin 4–6 hours 1–2 weeks
Table 3. Diagnostic tests.
Mechanical
complication of
acute MI
Coronary artery
typically involved
Time course Clinical findings Echocardiography
RV failure RCA Acute • Hypotension
and clear lungs
• Kussmaul sign
• Hypokinetic RV
Papillary muscle
rupture
RCA Acute and
within 3–5 days
• Acute severe
pulmonary
edema
• New
holosystolic
murmur
• Severe mitral regurtitation with
fail leaflet
Interventricular
septal rupture/defect
LAD: Apical septal
rupture
RCA: Basal septal
rupture
Acute and
within 3–5 days
• Shock and
chest pain
• New
holosystolic
murmur
• Biventricular
failure
• Left-to-right shunt at the level
of rupture
• Step-up oxygen level between
the right atrium and ventricle
Free wall rupture LAD Within first
5 days to
2 weeks
• Shock and
chest pain
• Jugular venous
distention
• Distant heart
sounds
• Pericardial effusion with
tamponade
Table 4 Evaluation of chest pain in the acute setting.
Involved myocardium Occluded vessel ECG leads involved
Anterior MI LAD Some or all of leads V1–V6
Inferior MI RCA or LCX ST elevation in leads II, III, and aVF
Right ventricular MI
(occurs in ½ of inferior MI)
RCA ST elevation in leads V4–V6R
Posterior MI LCX or RCA ST depression in leads V1–V3
ST elevation in leads I and aVL (LCX)
ST depression in leads I and aVL (RCA)
Lateral MI LCX, diagonal ST elevation in leads I, aVL, V5, and V6
ST depression in leads II, III, and aVF
Table 2. Myocardial infarction location based on coronary artery involvement.
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diabetes mellitus, hypertension, obesity, alcohol consumption, physical inactivity, and a diet low
in fruits and vegetables were strongly associated with acute MI in the 52 countries (Chart 1).
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